We compared different CSF biomarkers reflecting neurodegeneration (NFL) and inflammation (YKL-40, S100B and GFAP) in relation to core CSF AD markers and cognitive functions in a cohort of subjects at the pre- and early symptomatic dementia stages. This evidence concerns the gene GFAP and Alzheimer disease.